Does REGADENOSON Cause Injection site extravasation? 226 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 226 reports of Injection site extravasation have been filed in association with REGADENOSON (Regadenoson). This represents 7.4% of all adverse event reports for REGADENOSON.
226
Reports of Injection site extravasation with REGADENOSON
7.4%
of all REGADENOSON reports
1
Deaths
0
Hospitalizations
How Dangerous Is Injection site extravasation From REGADENOSON?
Of the 226 reports, 1 (0.4%) resulted in death.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGADENOSON. However, 226 reports have been filed with the FAERS database.
What Other Side Effects Does REGADENOSON Cause?
Nausea (311)
Dyspnoea (271)
Seizure (247)
Vomiting (233)
Hypotension (200)
Headache (190)
Cardiac arrest (183)
Dizziness (160)
Blood pressure decreased (143)
Chest pain (143)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
FREMANEZUMAB-VFRM (166)
Which REGADENOSON Alternatives Have Lower Injection site extravasation Risk?
REGADENOSON vs REGORAFENIB
REGADENOSON vs REGORAFENIB\REGORAFENIB
REGADENOSON vs RELATLIMAB
REGADENOSON vs RELPAX
REGADENOSON vs RELUGOLIX